Bone loss in very early inflammatory back pain in undifferentiated spondyloarthropathy: A 1-year observational study

Annals of the Rheumatic Diseases

Volumn 69, Issue 7, 2010, Pages 1364-1366

  Haugeberg, G ^a,b   Bennett, A N ^c   McGonagle, D ^d   Emery, P ^d   Marzo Ortega, H ^d  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b Sørlandet Hospital   (Norway)

^c CHAPEL ALLERTON HOSPITAL   (United Kingdom)

^d UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; BIOLOGICAL MARKER;

ADULT; ARTICLE; BACKACHE; BONE DENSITY; BONE MARROW EDEMA; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL STUDY; DISEASE ACTIVITY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HAND; HIP; HUMAN; LUMBAR SPINE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVATIONAL STUDY; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIOGRAPHY; SACROILIAC JOINT; SACROILIITIS; SPONDYLOARTHROPATHY; X RAY; BLOOD; FOLLOW UP; HAND BONE; LUMBAR VERTEBRA; METABOLIC BONE DISEASE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHOTON ABSORPTIOMETRY;

ABSORPTIOMETRY, PHOTON; ADULT; BACK PAIN; BIOLOGICAL MARKERS; BONE DENSITY; BONE DISEASES, METABOLIC; C-REACTIVE PROTEIN; FEMALE; FOLLOW-UP STUDIES; HAND BONES; HIP JOINT; HUMANS; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; SPONDYLARTHROPATHIES;

EID: 77955005446     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2009.124982     Document Type: Article

References (21)

1. Toussirot E, Michel F, Wendling D. Bone density, ultrasound measurements and body composition in early ankylosing spondylitis. Rheumatology (Oxford) 2001;40:882-8. (Pubitemid 32816059)
2. Gratacós J, Collado A, Pons F, et al. Significant loss of bone mass in patients with early, active ankylosing spondylitis: a followup study. Arthritis Rheum 1999;42:2319-24. (Pubitemid 30333411)
3. Haugeberg G, Green MJ, Quinn MA, et al. Hand bone loss in early undifferentiated arthritis: evaluating bone mineral density loss before the development of rheumatoid arthritis. Ann Rheum Dis 2006;65:736-40. (Pubitemid 43799171)
4. van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 1984;27:361-8.
5. Marzo-Ortega H, McGonagle D, O'Connor P, et al. Baseline and 1-year magnetic resonance imaging of the sacroiliac joint and lumbar spine in very early inflammatory back pain. Relationship between symptoms, HLA-B27 and disease extent and persistence. Ann Rheum Dis 2009;68:1721-7.
6. Bennett AN, McGonagle D, O'Connor P, et al. Severity of baseline magnetic resonance imaging-evident sacroiliitis and HLA-B27 status in early inflammatory back pain predict radiographically evident ankylosing spondylitis at eight years. Arthritis Rheum 2008;58:3413-18.
7. Rudwaleit M, van der Heijde D, Landewé R, et al. The development of Assessment of Spondyloarthritis International Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 2009;68:777-83.
8. Dougados M, van der Linden S, Juhlin R, et al. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 1991;34:1218-27.
9. Hollingsworth PN, Cheah PS, Dawkins RL, et al. Observer variation in grading sacroiliac radiographs in HLA-B27 positive individuals. J Rheumatol 1983;10:247-54.
10. Maillefert JF, Aho LS, El Maghraoui A, et al. Changes in bone density in patients with ankylosing spondylitis: a two-year follow-up study. Osteoporos Int 2001;12:605-9. (Pubitemid 32777439)
11. Franck H, Meurer T, Hofbauer LC. Evaluation of bone mineral density, hormones, biochemical markers of bone metabolism, and osteoprotegerin serum levels in patients with ankylosing spondylitis. J Rheumatol 2004;31:2236-41. (Pubitemid 39453245)
12. François RJ, Neure L, Sieper J, et al. Immunohistological examination of open sacroiliac biopsies of patients with ankylosing spondylitis: detection of tumour necrosis factor alpha in two patients with early disease and transforming growth factor beta in three more advanced cases. Ann Rheum Dis 2006;65:713-20. (Pubitemid 43799168)
13. Braun J, Brandt J, Listing J, et al. Long-term efficacy and safety of infliximab in the treatment of ankylosing spondylitis: an open, observational, extension study of a three-month, randomized, placebo-controlled trial. Arthritis Rheum 2003;48:2224-33. (Pubitemid 36959203)
14. Marzo-Ortega H, McGonagle D, Haugeberg G, et al. Bone mineral density improvement in spondyloarthropathy after treatment with etanercept. Ann Rheum Dis 2003;62:1020-1. (Pubitemid 37159510)
15. Marzo-Ortega H, McGonagle D, Jarrett S, et al. Infliximab in combination with methotrexate in active ankylosing spondylitis: a clinical and imaging study. Ann Rheum Dis 2005;64:1568-75. (Pubitemid 41532039)
16. Sarikaya S, Basaran A, Tekin Y, et al. Is osteoporosis generalized or localized to central skeleton in ankylosing spondylitis? J Clin Rheumatol 2007;13:20-4.
17. Barkham N, Keen HI, Coates LC, et al. Clinical and imaging efficacy of infliximab in HLA-B27-Positive patients with magnetic resonance imaging-determined early sacroiliitis. Arthritis Rheum 2009;60:946-54.
18. Appel H, Loddenkemper C, Grozdanovic Z, et al. Correlation of histopathological findings and magnetic resonance imaging in the spine of patients with ankylosing spondylitis. Arthritis Res Ther 2006;8:R143.
19. Vosse D, Landewé R, van der Heijde D, et al. Ankylosing spondylitis and the risk of fracture: results from a large primary care-based nested case-control study. Ann Rheum Dis 2009;68:1839-42.
20. Jun JB, Joo KB, Her MY, et al. Femoral bone mineral density is associated with vertebral fractures in patients with ankylosing spondylitis: a cross-sectional study. J Rheumatol 2006;33:1637-41.
21. Geusens P, Vosse D, van der Linden S. Osteoporosis and vertebral fractures in ankylosing spondylitis. Curr Opin Rheumatol 2007;19:335-9.